• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Autosomal recessive polycystic kidney disease in 115 children: clinical presentation, course and influence of gender. Arbeitsgemeinschaft für Pädiatrische, Nephrologie.

作者信息

Zerres K, Rudnik-Schöneborn S, Deget F, Holtkamp U, Brodehl J, Geisert J, Schärer K

机构信息

Institut für Humangenetik, Universität Bonn, FRG.

出版信息

Acta Paediatr. 1996 Apr;85(4):437-45. doi: 10.1111/j.1651-2227.1996.tb14056.x.

DOI:10.1111/j.1651-2227.1996.tb14056.x
PMID:8740301
Abstract

The clinical course of 66 boys and 49 girls with autosomal recessive polycystic kidney disease recruited from departments of paediatric nephrology was investigated over a mean observation period of 4.92 years. This is a selected study group of children from departments of paediatric nephrology who in most cases survived the neonatal period, since birth clinics did not participate. The median age at diagnosis was 29 days (prenatal to 14.5 years). We observed decreased glomerular filtration rates (GFRs) in 72% (median age at onset of decrease of GFR < 2 SD, 0.6 years; range, 0-18.7 years), and 11 patients developed end-stage renal disease. Hypertension requiring drug treatment was found in 70% (median age at start of medication, 0.5 years; range, 0-16.7 years). Kidney length was above the 97th centile in 68% of patients, and kidney length did not increase with age or deterioration of renal function. Urinary tract infections occurred in 30%, growth retardation in 25%, and clinical signs of hepatic fibrosis were detected in 46%. Thirteen patients (11%) died during the observation period, 10 of them in the first year of life. There was a statistically significant sex difference in terms of a more pronounced progression in girls. The survival probability at 1 year was 94% for male patients and 82% for female patients (p < 0.05) in this study. Urinary tract infections occurred more frequently in girls (p < 0.025) and were observed earlier. In addition, more girls had impaired renal function, developed end-stage renal disease and showed growth retardation; these differences, however, were not significant. For the children in this study, however, our results indicate that the long-term prognosis in the majority of cases is better throughout childhood and youth than often stated.

摘要

相似文献

1
Autosomal recessive polycystic kidney disease in 115 children: clinical presentation, course and influence of gender. Arbeitsgemeinschaft für Pädiatrische, Nephrologie.
Acta Paediatr. 1996 Apr;85(4):437-45. doi: 10.1111/j.1651-2227.1996.tb14056.x.
2
Body growth in children with polycystic kidney disease. Arbeitsgemeinschaft für Pädiatrische Nephrologie.
Acta Paediatr. 1995 Nov;84(11):1227-32. doi: 10.1111/j.1651-2227.1995.tb13538.x.
3
Autosomal recessive polycystic kidney disease: long-term outcome of neonatal survivors.常染色体隐性多囊肾病:新生儿幸存者的长期预后
Pediatr Nephrol. 1997 Jun;11(3):302-6. doi: 10.1007/s004670050281.
4
Phenotypic variation and long-term outcome in children with congenital hepatic fibrosis.先天性肝纤维化患儿的表型变异和长期预后。
J Pediatr Gastroenterol Nutr. 2013 Aug;57(2):161-6. doi: 10.1097/MPG.0b013e318291e72b.
5
Autosomal recessive polycystic kidney disease: outcomes from a single-center experience.常染色体隐性多囊肾病:单中心经验的结果
Pediatr Nephrol. 2003 Feb;18(2):119-26. doi: 10.1007/s00467-002-1021-0. Epub 2003 Jan 21.
6
Kidney Versus Combined Kidney and Liver Transplantation in Young People With Autosomal Recessive Polycystic Kidney Disease: Data From the European Society for Pediatric Nephrology/European Renal Association-European Dialysis and Transplant (ESPN/ERA-EDTA) Registry.常染色体隐性遗传性多囊肾病患者行肾移植与肾联合肝移植的对比:来自欧洲儿科学会肾脏学会/欧洲肾脏协会-欧洲透析和移植协会(ESPN/ERA-EDTA)注册中心的数据。
Am J Kidney Dis. 2016 Nov;68(5):782-788. doi: 10.1053/j.ajkd.2016.06.019. Epub 2016 Aug 21.
7
Liver disease in autosomal recessive polycystic kidney disease: clinical characteristics and management in relation to renal failure.常染色体隐性多囊肾病中的肝脏疾病:与肾衰竭相关的临床特征及管理
J Pediatr Gastroenterol Nutr. 2014 Aug;59(2):190-6. doi: 10.1097/MPG.0000000000000422.
8
Autosomal recessive polycystic kidney disease: the clinical experience in North America.常染色体隐性多囊肾病:北美地区的临床经验
Pediatrics. 2003 May;111(5 Pt 1):1072-80. doi: 10.1542/peds.111.5.1072.
9
Childhood onset autosomal dominant polycystic kidney disease in sibs: clinical picture and recurrence risk. German Working Group on Paediatric Nephrology (Arbeitsgemeinschaft für Pädiatrische Nephrologie.同胞中儿童期起病的常染色体显性多囊肾病:临床表现及复发风险。德国儿科肾脏病工作组(儿科肾脏病协作组)
J Med Genet. 1993 Jul;30(7):583-8. doi: 10.1136/jmg.30.7.583.
10
Recombinant human growth hormone therapy in autosomal recessive polycystic kidney disease.重组人生长激素疗法治疗常染色体隐性多囊肾病
Pediatr Nephrol. 2003 Jan;18(1):57-61. doi: 10.1007/s00467-002-0986-z. Epub 2002 Nov 26.

引用本文的文献

1
Multi-omics analysis of host-microbiome interactions in a mouse model of congenital hepatic fibrosis.先天性肝纤维化小鼠模型中宿主-微生物组相互作用的多组学分析
BMC Microbiol. 2025 Mar 31;25(1):176. doi: 10.1186/s12866-025-03892-x.
2
Variable Clinical Presentations and Renal Outcome in Neonates With Autosomal Recessive Polycystic Kidney Disease.常染色体隐性遗传性多囊肾病新生儿的可变临床表现及肾脏转归
Cureus. 2024 May 9;16(5):e59993. doi: 10.7759/cureus.59993. eCollection 2024 May.
3
A novel ARPKD mouse model with near-complete deletion of the Polycystic Kidney and Hepatic Disease 1 (Pkhd1) genomic locus presents with multiple phenotypes but not renal cysts.
一种新型常染色体隐性多囊肾病小鼠模型,其多囊肾和肝病 1(Pkhd1)基因组位点几乎完全缺失,表现出多种表型,但无肾囊肿。
Kidney Int. 2023 Sep;104(3):611-616. doi: 10.1016/j.kint.2023.05.027. Epub 2023 Jul 5.
4
Autosomal dominant and autosomal recessive polycystic kidney disease: hypertension and secondary cardiovascular effect in children.常染色体显性和常染色体隐性多囊肾病:儿童高血压及继发性心血管影响
Front Mol Biosci. 2023 Mar 10;10:1112727. doi: 10.3389/fmolb.2023.1112727. eCollection 2023.
5
Evaluation of galectin-3 and intestinal fatty acid binding protein as serum biomarkers in autosomal recessive polycystic kidney disease.评估半乳糖凝集素-3和肠道脂肪酸结合蛋白作为常染色体隐性多囊肾病血清生物标志物的作用。
J Nephrol. 2023 Jan;36(1):133-145. doi: 10.1007/s40620-022-01416-8. Epub 2022 Aug 18.
6
The Enigma of Clinical Heterogeneity Among Autosomal Recessive Polycystic Kidney Disease Siblings: Genotype Versus Other Genomic or Environmental Modifier.常染色体隐性多囊肾病患者临床异质性之谜:基因型与其他基因组或环境修饰因素
Kidney Int Rep. 2022 May 2;7(7):1453-1455. doi: 10.1016/j.ekir.2022.04.092. eCollection 2022 Jul.
7
Phenotypic Variability in Siblings With Autosomal Recessive Polycystic Kidney Disease.常染色体隐性多囊肾病患者兄弟姐妹的表型变异性
Kidney Int Rep. 2022 May 4;7(7):1643-1652. doi: 10.1016/j.ekir.2022.04.095. eCollection 2022 Jul.
8
Molecular Pathophysiology of Autosomal Recessive Polycystic Kidney Disease.常染色体隐性遗传性多囊肾病的分子病理生理学。
Int J Mol Sci. 2021 Jun 17;22(12):6523. doi: 10.3390/ijms22126523.
9
Fibrocystic liver disease: novel concepts and translational perspectives.纤维囊性肝病:新观念与转化医学视角
Transl Gastroenterol Hepatol. 2021 Apr 5;6:26. doi: 10.21037/tgh-2020-04. eCollection 2021.
10
Early clinical management of autosomal recessive polycystic kidney disease.常染色体隐性遗传性多囊肾病的早期临床管理。
Pediatr Nephrol. 2021 Nov;36(11):3561-3570. doi: 10.1007/s00467-021-04970-8. Epub 2021 Feb 17.